Ortin Laboratories Limited has reported Standalone financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 2.6219 crores during the period ended June 30, 2022 as compared to Rs. 2.4517 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. -0.4267 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -0.4533 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. -0.5247 for the period ended June 30, 2022 as compared to Rs. -0.56 for the period ended March 31, 2022.
Total Income | ₹2.6219 crs | ₹2.4517 crs | 6.94% |
Net Profit | ₹-0.4267 crs | ₹-0.4533 crs | 5.87% |
EPS | ₹-0.5247 | ₹-0.56 | 6.30% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs.2.6219 crores during the period ended June 30, 2022 as compared to Rs.1.9848 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.-0.4267 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.0911 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.-0.5247 for the period ended June 30, 2022 as compared to Rs.0.11 for the period ended June 30, 2021.
Total Income | ₹2.6219 crs | ₹1.9848 crs | 32.10% |
Net Profit | ₹-0.4267 crs | ₹0.0911 crs | -568.39% |
EPS | ₹-0.5247 | ₹0.11 | -577.00% |
Shares of Ortin Laboratories Limited was last trading in BSE at Rs. 23.75 as compared to the previous close of Rs. 24.60. The total number of shares traded during the day was 3359 in over 95 trades.
The stock hit an intraday high of Rs. 24.65 and intraday low of 23.65. The net turnover during the day was Rs. 80351.00.
Source : Equity Bulls
Keywords
OrtinLaboratories
Q1FY23
ResultUpdate